University of California San Francisco
Give to UCSF
<p>Francis Collins, director of the National Institutes of Health (NIH), describes the scientific goals and functions of the National Center for Advancing Translational Sciences (NCATS), a proposed new entity of the NIH that will strive to reengineer the process of developing drugs, diagnostics, and devices. </p>
<p>UCSF cognitive neuroscientist Adam Gazzaley has used functional brain imaging and EEG studies to discover that older adults fare worse than younger adults at remembering following distractions. He hopes to improve their performance with cognitive training, using a newly developed video game.</p>
Researchers at UCSF and in Michigan, North Carolina and Spain have discovered how genetic mutations cause a number of rare human diseases, which include Meckel syndrome, Joubert syndrome and several other disorders.
<p>Each year, scores of soldiers wounded by explosives suffer from debilitating nerve injuries that render their arms and legs useless. Kim’s research, performed at the UCSF-affiliated San Francisco Veterans Affairs hospital, has led to development of artificial nerve grafts to accelerate healing of these injuries.</p>
<p>Having developed an algorithm that discovered a large quantity of drug-producing bacteria in and on humans, Fischbach has turned his lab’s attention to studying their populations and interactions with each other. This, he posits, can greatly influence a person’s overall health and disease.</p>
<p>By mapping neurons and neuron circuitry during movement, Sabes’ lab hopes to one day to be able to print this information back into the brain. If feasible, such therapy could offer new hope to stroke victims whose brains are unable to recover on their own.</p>
<p>Many researchers are finding that by the time a patient seeks treatment for symptoms of Alzheimer’s disease, it’s often too late for the available drugs to have an effect. Boxer’s lab is studying very precise eye tracking methods to gauge mental fitness and identify cognitive decline decades before the first symptoms appear.</p>
<p>Swallowing pills means medication must face the challenge of surviving the harsh environment of the digestive tract. As a result, people must take larger doses than they need. Using micro and nano-fabrication techniques developed by the computer chip industry, Desai’s lab is creating tiny devices that take multiple drugs directly to where they are needed, using less medication, minimizing side effects and making the process safer for the patient. </p>
Stem cell transplantation may hold the promise to treating many diseases before birth such as sickle cell anemia and muscular dystrophy. But first, researchers need to overcome many barriers, including rejection of stem cell transplants by the fetus. MacKenzie’s lab recently discovered that mothers’ T cells are responsible for rejecting the grafts and that this rejection may be avoided by using stem cells from the mother.
A 10-month study of healthy honey bees by UCSF scientists has identified four new viruses that infect bees, while revealing that each of the viruses or bacteria previously linked to colony collapse is present in healthy hives as well.
<p>Experts at UCSF and Caltech are pushing the boundaries of creative problem solving to address important clinical problems with the hope that the talent pool at both institutions, combined with an entrepreneurial spirit, will advance health care innovation.</p>
<p>Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.</p>
Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
<p>Scientists are making great strides in figuring out how the human brain develops, which are leading to novel ideas about the causes of a range of brain disorders, and are raising hopes for the regeneration of tissue that is lost in diseases such as Alzheimer’s. </p>
Scientists at UCSF have pinpointed a reason older adults have a harder time multitasking than younger adults: they have more difficulty switching between tasks at the level of brain networks.
Researchers exploring human metabolism at UCSF have uncovered a handful of chemical compounds that regulate fat storage in worms, offering a new tool for understanding obesity and finding future treatments for diseases associated with obesity.
Five basic scientists at UCSF will be awarded the distinction of fellows by the American Association for the Advancement of Science (AAAS) on February 19.
UCSF researchers have developed a new approach to decoding the vast information embedded in an organism’s genome, while shedding light on exactly how cells interpret their genetic material to create RNA messages and launch new processes in the cell.
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
Sanofi-Aventis and UCSF have formed two research and development collaborations that join together leaders from academia and industry to more rapidly advance groundbreaking innovation from the lab to the patient.
Susan Hyde, an award-winning professor and scientist with the UCSF School of Dentistry, promotes practices that preserve oral health and quality of life for both patients and practitioners.
Parkinson’s disease researcher Robert Nussbaum, a human geneticist and neuroscientist at UCSF, has been named to receive the prestigious Klaus Joachim Zülch Neuroscience Prize for 2011.
Weight gain and environmental pollutants might be linked, an award-winning worm researcher suggests.
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.
A team of UCSF researchers has engineered E. coli with the key molecular circuitry that will enable genetic engineers to program cells to communicate and perform computations.